Bourne Partners Advises Woodward Pharma on Branded Pharmaceuticals Acquisitions and $125 Million Financing
August 18, 2021
Charlotte, NC – Bourne Partners served as the exclusive financial advisor to Woodward Pharma Services, LLC (“Woodward”) and its affiliate Future Pak Ltd. (“Future Pak”) in the acquisitions of branded pharmaceutical products and a $125 million financing.
Woodward and Future Pak, headquartered in Wixom, MI, are headed by industry veterans, David Risk and Ray Canole. Woodward is a specialty pharmaceutical company focused on acquiring, licensing, and commercializing branded and generic prescription drugs for the U.S. market. Future Pak is a pharmaceutical and over-the-counter contract manufacturing and packaging organization.
The funding, provided by Colbeck Capital Management (“Colbeck”), is being used to accelerate company growth by expanding the platform and acquiring branded pharmaceutical products from long-standing relationships.
“We are excited about closing these acquisitions and the financing with Colbeck and look forward to helping Woodward acquire additional pharma assets to further scale the company,” said Robert Stanley, Director and Head of Pharma Coverage at Bourne Partners.
For additional information on these transactions or to discuss potential add-on M&A opportunities that may be a fit for Woodward or Future Pak, please reach out to Robert Stanley at email@example.com or 704-714-8354.
About Woodward Pharma Services and Future Pak
Woodward Pharma Services LLC is a specialty pharmaceutical company focused on acquiring, licensing, and commercializing branded and generic prescription drugs for the U.S. market. The Company has a diverse portfolio of products distributed across multiple channels. www.woodwardpharma.com/
Future Pak Ltd. is a pharmaceutical and over-the-counter contract manufacturing and packaging operation. www.futurepak.com/
About Colbeck Capital Management
Colbeck Capital Management is a strategic lender that partners with companies during periods of transition, providing creative capital solutions to meet their evolving needs. Founded in 2009 by Jason Colodne and Jason Beckman, Colbeck Capital has offices in New York City and Los Angeles. www.colbeck.com/
ABOUT BOURNE PARTNERS
Bourne Partners is a financial services firm specializing in the pharma, pharma services, OTC and consumer health sectors. Located in Charlotte, North Carolina, the company offers investment banking and advisory services. Through Bourne Partners Strategic Capital (“BPSC”), Bourne invests and manages private equity investments in companies within the firm’s core focus areas. As owners and operators with over 20 years of experience, Bourne Partners strives to enrich the lives and improve the health and well-being of their partners and patients across the globe by facilitating the efficient movement of capital through the global healthcare sector. For more information, please visit www.bourne-partners.com.